Početna › Burkittov limfom › Florida

Kliničke studije za Burkittov limfom u državi Florida

15 studija za Burkittov limfom traži sudionike na lokacijama u državi Florida.

Gradovi u državi Florida

Službeni tekst studije (engleski)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
i još 9

U tijeku regrutacijaFaza 2

366 Days – 46 Years · Oba spola · Ažurirano 2. lis 2026. · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Orlando Health Cancer Institute, Orlando

U tijeku regrutacijaFaza 3

Od 18 do 39 godina · Oba spola · Ažurirano 2. lis 2026. · NCT03150693

Blinatumomab Consolidation in Real World

Mayo Clinic Cancer Center, Jacksonville

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli

Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07117136

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Jupiter Medical Center, Jupiter

U tijeku regrutacijaFaza 2

Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT03739814

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Moffitt Cancer Center, Tampa

U tijeku regrutacijaFaza 2

Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06144606

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Nemours Children's Clinic-Jacksonville, Jacksonville
i još 8

U tijeku regrutacijaFaza 2

365 Days · Oba spola · Ažurirano 25. ruj 2026. · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

SSAK Partners, Coral Springs
Mayo Clinic - Jacksonville, Jacksonville

U tijeku regrutacijaFaza 3

Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg

U tijeku regrutacijaFaza 1/2

6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

H. Lee Moffitt Cancer Center, Tampa

U tijeku regrutacijaFaza 1

Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
i još 9

U tijeku regrutacijaFaza 2

Od 1 do 30 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
i još 12

U tijeku regrutacijaFaza 3

365 Days – 25 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Tampa

U tijeku regrutacijaFaza 1/2

Od 12 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

U tijeku regrutacijaFaza 1/2

Od 13 do 90 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06533579

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

U tijeku regrutacijaFaza 1

Od 18 godina i više · Oba spola · Ažurirano 13. velj 2026. · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami
Johns Hopkins All Children's Hospital, St. Petersburg

U tijeku regrutacijaFaza 2

Od 1 do 25 godina · Oba spola · Ažurirano 4. svi 2025. · NCT03509961

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.